Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 23, 2026

Feb. 23, 2026

Expanding CTE Programs Would Help Michigan Overcome Its Shortage of Behavioral Health Professionals, New Report Finds

EIN Presswire

Feb. 23, 2026

Supernus Pharmaceuticals to Participate in March Investor Conferences

GlobeNewswire

Feb. 23, 2026

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

GlobeNewswire

Feb. 23, 2026

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

GlobeNewswire

Feb. 23, 2026

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

GlobeNewswire

Feb. 23, 2026

Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations

GlobeNewswire

Feb. 23, 2026

Smith+Nephew signs distribution agreement with SI-BONE

GlobeNewswire

Feb. 23, 2026

Ultragenyx to Participate at Investor Conferences in March

GlobeNewswire

Feb. 23, 2026

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 23, 2026

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

GlobeNewswire

Feb. 23, 2026

Silo Pharma Announces Share Buyback Program

GlobeNewswire

Feb. 23, 2026

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

GlobeNewswire

Feb. 23, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

GlobeNewswire

Feb. 23, 2026

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

GlobeNewswire

Feb. 23, 2026

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

GlobeNewswire

Feb. 23, 2026

Sana Biotechnology to Present at March 2026 Investor Conferences

GlobeNewswire

Feb. 23, 2026

MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

GlobeNewswire

Feb. 23, 2026

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates

GlobeNewswire

Feb. 23, 2026

Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements

GlobeNewswire

Feb. 23, 2026

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

GlobeNewswire